Noninvasive Transcutaneous Glucometer Development
Recruiting in Palo Alto (17 mi)
MR
Overseen byMark Rohrscheib, M.D.
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: InLight Solutions
No Placebo Group
Trial Summary
What is the purpose of this trial?
The objective of this study is to assist in the development of a noninvasive device for the accurate measurement of blood glucose levels.
Research Team
MR
Mark Rohrscheib, M.D.
Principal Investigator
UNMHSC
Eligibility Criteria
Inclusion Criteria
18 years of age or older
Healthy
Type I diabetics
See 2 more
Treatment Details
Interventions
- Noninvasive Transcutaneous Glucometer (Other)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
InLight SolutionsAlbuquerque, NM
Loading ...
Who Is Running the Clinical Trial?
InLight Solutions
Lead Sponsor
Trials
7
Patients Recruited
2,300+